SCAD
8
4
5
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD)
The "Virtual" Multicenter Spontaneous Coronary Artery Dissection (SCAD) Registry
Norwegian Spontaneous Coronary Artery Dissection Study
Effects of Edoxaban on Platelet Aggregation
Impact of CYP2C19 Genotype-guided Approach in Antiplatelet Therapy on Platelet Reactivity Index Among Coronary Artery Disease (CAD) Patients
Clinical Cohort Study - INTERCATH
Canadian SCAD Study
Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity